| http://www.w3.org/ns/prov#value | - Ongoing Phase II Masitinib (AB1010) Trial - Dr. Jean-Yves Blay from the French Sarcoma Group did not have new information to divulge about his this trial other than there is a delay due to stalled resources of the lab and it will be two to three years before the accruing results are made public.
|
